omadahealth.comHealthcare / Digital HealthFounded: 2011Funding to Date: $459.88MM
Omada Health, founded in 2011, is a digital health company that aims to help individuals achieve their wellness objectives by fostering long-lasting lifestyle modifications. The company offers a comprehensive digital care program, which provides personalized support and guidance seeking to empower users in taking charge of their health and well-being. Omada Health is headquartered in San Francisco, California.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/23/2022 | Series E | $192MM | $xx.xx | $1.02B | Fidelity, aMoon, Perceptive Advisors, Wellington Management, Civilization Ventures | |
Price per Share
$xx.xx
Shares Outstanding
32,025,620
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Fidelity, aMoon, Perceptive Advisors, Wellington Management, Civilization Ventures
|
||||||
03/16/2021 | Series D-1 | $27MM | $xx.xx | $780.77MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,503,601
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
05/19/2020 | Series D | $112.47MM | $xx.xx | $612.85MM | Perceptive Advisors, Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, Sanofi-Genzyme Bioventures, US Venture Partners, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
22,330,212
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Perceptive Advisors, Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, Sanofi-Genzyme Bioventures, US Venture Partners, Wellington Management
|
||||||
05/10/2017 | Series C-1 | $49.99MM | $xx.xx | $320.25MM | Cigna, Civilization Ventures, Sanofi Genzyme BioVentures, U.S. Venture Partners, Andreessen Horowitz, Norwest Venture Partners, Humana, Kaiser Permanente Ventures, Providence Ventures, dRx Capital, GE Ventures | |
Price per Share
$xx.xx
Shares Outstanding
13,357,797
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Cigna, Civilization Ventures, Sanofi Genzyme BioVentures, U.S. Venture Partners, Andreessen Horowitz, Norwest Venture Partners, Humana, Kaiser Permanente Ventures, Providence Ventures, dRx Capital, GE Ventures
|
||||||
10/01/2015 | Series C | $48.67MM | $xx.xx | $216.43MM | Norwest Venture Partners, Providence Ventures, Humana Ventures, US Venture Partners, Rock Health, Andreessen Horowitz, Designer Fund, GE Ventures, IDEO Futures, dRx Capital | |
Price per Share
$xx.xx
Shares Outstanding
15,385,707
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Norwest Venture Partners, Providence Ventures, Humana Ventures, US Venture Partners, Rock Health, Andreessen Horowitz, Designer Fund, GE Ventures, IDEO Futures, dRx Capital
|
||||||
04/09/2014 | Series B | $23.33MM | $xx.xx | $60.57MM | Andreessen Horowitz, Kaiser Permanente Ventures, U.S. Venture Partners, The Vertical Group | |
Price per Share
$xx.xx
Shares Outstanding
19,724,378
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, Kaiser Permanente Ventures, U.S. Venture Partners, The Vertical Group
|
||||||
03/21/2013 | Series A | $6.43MM | $xx.xx | $16.11MM | U.S. Venture Partners, The Vertical Group, Founder Collective, New Enterprise Associates, TriplePoint Capital, Kapor Capital, HealthTech Capital | |
Price per Share
$xx.xx
Shares Outstanding
12,027,426
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
U.S. Venture Partners, The Vertical Group, Founder Collective, New Enterprise Associates, TriplePoint Capital, Kapor Capital, HealthTech Capital
|